Eccogene

CRO focused on development of drugs for metabolic and immune-related diseases

placePudong, Shanghai, China calendar_todayFounded 2018 language eccogene.com

Innovation

4 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 40 times.

YearFilings
20222
20231
20242
20253
20261

Social engagement

Social engagement: 1.1K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Yuanhe Holdings, New Alliance Capital.

Investor typeCountShare
Venture capital330%
Private equity550%
Other / undisclosed220%

Recent activity

1 Jun 2026
Event
American Diabetes Association's 2026 Scientific Sessions
11 Feb 2026
Milestone
regulatory
16 Dec 2025
Milestone
regulatory
Coming soon